Found: 51
Select item for more details and to access through your institution.
Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved Outcomes.
- Published in:
- Movement Disorders Clinical Practice, 2019, v. 6, n. 3, p. 222, doi. 10.1002/mdc3.12724
- By:
- Publication type:
- Article
Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.
- Published in:
- Neurological Sciences, 2011, v. 32, n. 1, p. 159, doi. 10.1007/s10072-010-0386-2
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 3, p. 324, doi. 10.1002/cpdd.1039
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 4, p. 393, doi. 10.1002/cpdd.874
- By:
- Publication type:
- Article
Single and multiple ascending dose studies in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057728
- By:
- Publication type:
- Article
Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme, following administration of single and multiple doses to healthy volunteers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057774
- By:
- Publication type:
- Article
Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme: Translation from rat to human: Neuroimaging / evaluating treatments.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040558
- By:
- Publication type:
- Article
A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme: Human/Human trials: Anti‐tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040473
- By:
- Publication type:
- Article
P1‐057: A MULTIPLE ASCENDING‐DOSE STUDY OF THE PHARMACOKINETICS AND SAFETY OF LY3154207, A CENTRALLY‐ACTING DOPAMINE D1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR (D1 PAM), IN HEALTHY SUBJECTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P254, doi. 10.1016/j.jalz.2019.06.082
- By:
- Publication type:
- Article
A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders.
- Published in:
- Health Informatics Journal, 2016, v. 22, n. 2, p. 304, doi. 10.1177/1460458214556373
- By:
- Publication type:
- Article
Refining the diagnosis of Huntington disease: the PREDICT-HD study.
- Published in:
- Frontiers in Aging Neuroscience, 2013, p. 1, doi. 10.3389/fnagi.2013.00012
- By:
- Publication type:
- Article
Refining the diagnosis of Huntington Disease: The PREDICT-HD study.
- Published in:
- Frontiers in Aging Neuroscience, 2013, p. 1, doi. 10.3389/fnagi.2013.00012
- By:
- Publication type:
- Article
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13195-020-00703-5
- By:
- Publication type:
- Article
Surrogate endpoints in Parkinson’s disease research.
- Published in:
- Current Neurology & Neuroscience Reports, 2003, v. 3, n. 4, p. 314, doi. 10.1007/s11910-003-0008-y
- By:
- Publication type:
- Article
Initial treatment of early Parkinson’s disease: A review of recent, randomized controlled trials.
- Published in:
- Current Neurology & Neuroscience Reports, 2001, v. 1, n. 4, p. 329, doi. 10.1007/s11910-001-0086-7
- By:
- Publication type:
- Article
Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists.
- Published in:
- Telemedicine & e-Health, 2018, v. 24, n. 9, p. 722, doi. 10.1089/tmj.2017.0210
- By:
- Publication type:
- Article
Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study.
- Published in:
- Telemedicine & e-Health, 2018, v. 24, n. 4, p. 255, doi. 10.1089/tmj.2017.0119
- By:
- Publication type:
- Article
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.
- Published in:
- Telemedicine & e-Health, 2016, v. 22, n. 7, p. 590, doi. 10.1089/tmj.2015.0191
- By:
- Publication type:
- Article
Willingness of Parkinson's Disease Patients to Participate in Research Using Internet-Based Technology.
- Published in:
- Telemedicine & e-Health, 2012, v. 18, n. 9, p. 684, doi. 10.1089/tmj.2011.0276
- By:
- Publication type:
- Article
Measuring Disease Progression in Early Parkinson Disease The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 6, p. 710, doi. 10.1001/jamaneurol.2014.391
- By:
- Publication type:
- Article
Natural History of Huntington Disease.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 12, p. 1520, doi. 10.1001/jamaneurol.2013.4408
- By:
- Publication type:
- Article
Randomized Controlled Clinical Trial of "Virtual House Calls" for Parkinson Disease.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 5, p. 565, doi. 10.1001/jamaneurol.2013.123
- By:
- Publication type:
- Article
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study.
- Published in:
- PLoS Currents, 2011, p. 665, doi. 10.1371/currents.RRN1283
- By:
- Publication type:
- Article
Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease.
- Published in:
- PLoS Currents, 2011, p. 200, doi. 10.1371/currents.RRN1244
- By:
- Publication type:
- Article
Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia.
- Published in:
- Digital Biomarkers, 2023, v. 7, n. 1, p. 54, doi. 10.1159/000529623
- By:
- Publication type:
- Article
Design of a virtual longitudinal observational study in Parkinson's disease (AT‐HOME PD).
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 2, p. 308, doi. 10.1002/acn3.51236
- By:
- Publication type:
- Article
A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III).
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 6, p. 360, doi. 10.1002/acn3.412
- By:
- Publication type:
- Article
Erratum To: Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.
- Published in:
- Trials, 2014, v. 15, n. 1, p. 2, doi. 10.1186/1745-6215-15-465
- By:
- Publication type:
- Article
Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial.
- Published in:
- Movement Disorders, 2022, v. 37, n. 3, p. 513, doi. 10.1002/mds.28879
- By:
- Publication type:
- Article
Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 1, p. 177, doi. 10.1007/s40120-022-00417-w
- By:
- Publication type:
- Article
Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00868-7
- By:
- Publication type:
- Article
Telemedicine Care for Nursing Home Residents with Parkinsonism.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Moving Parkinson care to the home.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1404, doi. 10.1002/mds.26014
- By:
- Publication type:
- Article
Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
The past, present, and future of telemedicine for Parkinson's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 7, p. 871, doi. 10.1002/mds.25903
- By:
- Publication type:
- Article
The Past, Present, and Future of Telemedicine for Parkinson's Disease.
- Published in:
- Movement Disorders, 2014, v. 29, p. 871, doi. 10.1002/mds.25903
- By:
- Publication type:
- Article
Results of the citalopram to enhance cognition in Huntington disease trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Results of the citalopram to enhance cognition in Huntington disease trial.
- Published in:
- Movement Disorders, 2014, v. 29, n. 3, p. 401, doi. 10.1002/mds.25750
- By:
- Publication type:
- Article
Web-based clinical assessments for Parkinson's disease: Reliable and feasible.
- Published in:
- Movement Disorders, 2012, v. 27, n. 11, p. 1466, doi. 10.1002/mds.25121
- By:
- Publication type:
- Article
Reply: An exploration of the burden experienced by spousal caregivers of individuals with Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 13, p. 2254, doi. 10.1002/mds.23273
- By:
- Publication type:
- Article
A U.S. survey of patients with Parkinson's disease: Satisfaction with medical care and support groups.
- Published in:
- Movement Disorders, 2010, v. 25, n. 13, p. 2128, doi. 10.1002/mds.23160
- By:
- Publication type:
- Article
Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 11, p. 1652, doi. 10.1002/mds.23145
- By:
- Publication type:
- Article
Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study.
- Published in:
- Movement Disorders, 2009, v. 24, n. 12, p. 1763, doi. 10.1002/mds.22601
- By:
- Publication type:
- Article
Telemedicine for the care of nursing home residents with Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 7, p. 1073, doi. 10.1002/mds.22498
- By:
- Publication type:
- Article
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study.
- Published in:
- Movement Disorders, 2009, v. 24, n. 2, p. 277, doi. 10.1002/mds.22307
- By:
- Publication type:
- Article
The relationship between CAG repeat length and clinical progression in Huntington's disease.
- Published in:
- Movement Disorders, 2008, v. 23, n. 9, p. 1223, doi. 10.1002/mds.21988
- By:
- Publication type:
- Article